CV/
@damiangarde
BETA
Claim Your CV
What is a CV?
Login
Connect
Damian Garde
cv/@damiangarde
@statnews biotech reporter | damian.garde@statnews.com | Signal/WhatsApp: 202-780-9154
Categories
N/A
Content Types
N/A
More Information
Location
|
Languages
Publications
N/A
Show More
Filters
Published Content
29
statnews.com
Article
Drug makers looking to replace opioids try to keep some pain in the picture
statnews.com
Article
Loxo Oncology's cancer drug wins a pioneering FDA approval
statnews.com
Article
Moderna aims to raise $500 million in biotech's largest-ever public offering
statnews.com
Article
Former CDC director Tom Frieden arrested on sexual misconduct charges
statnews.com
Article
Alzheimer's study sparks a new round of debate over the amyloid hypothesis
statnews.com
Article
Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline
statnews.com
Article
FDA approves a game-changing treatment for blood cancer
statnews.com
Article
Pioneering cancer drug will cost $475,000. Analysts call it a bargain
statnews.com
Article
FDA reverses course on drug developed by CEO with ties to Trump
statnews.com
Article
China rises as a biotech powerhouse, developing drugs to treat the world
statnews.com
Article
How a drug ad made its way into 'General Hospital'
statnews.com
Article
These five biotech CEOs earned big bucks even as their companies tanked
statnews.com
Article
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
statnews.com
Article
Who really wants to blow up the FDA? Not the drug industry
statnews.com
Article
Has the drug industry been cowed into silence by the tweeter-in-chief?
statnews.com
Article
Top academics lash out at Trump's 'un-American' immigration ban
statnews.com
Article
Diabetes finding once heralded as breakthrough is retracted
statnews.com
Article
Alzheimer’s drug fails in late-stage trial, dashing hopes
statnews.com
Article
What does Donald Trump's win mean for science and medicine?
statnews.com
Article
Raising 'good' cholesterol doesn't reduce heart attack risk
statnews.com
Article
Alzheimer's drug trial could offer real hope — or crush it
statnews.com
Article
Inside Moderna Therapeutics, biotech's most secretive startup
statnews.com
Article
Controversial CEO in the hot seat over EpiPen price hikes
statnews.com
Article
How biotech executives profit from legal insider trading
statnews.com
Article
The cure for ‘bubble boy’ disease will cost $665,000
statnews.com
Article
An ex-con takes indebted biotech Kadmon public, raising eyebrows
statnews.com
Article
FDA lets cancer trial resume after three patient deaths
statnews.com
Article
Juno halts immunotherapy trial for cancer after patient deaths
statnews.com
Article
Could a molecular 'agony switch' lead to a safer painkiller?